Shilanski & Associates, Inc. Amgen Inc Transaction History

Shilanski & Associates, Inc.

$296 Million
Q2 2024

A detailed history of Shilanski & Associates, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Shilanski & Associates, Inc. holds 900 shares of AMGN stock, worth $265,077. This represents 0.09% of its overall portfolio holdings.

Number of Shares

900

Previous 904 0.44%

Holding current value

$265,077

Previous $257,000 9.34%

% of portfolio

0.09%

Previous 0.09%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 18, 2024	SELL	$262.75 - $319.31 $1,051 - $1,277	-4 Reduced 0.44%	900 $281,000
Q1 2024 Apr 10, 2024	SELL	$268.87 - $324.56 $47,321 - $57,122	-176 Reduced 16.3%	904 $257,000
Q4 2023 Jan 09, 2024	SELL	$255.7 - $288.46 $15,342 - $17,307	-60 Reduced 5.26%	1,080 $311,000
Q3 2023 Nov 13, 2023	BUY	$218.65 - $271.46 $218 - $271	1 Added 0.09%	1,140 $306,000
Q2 2023 Jul 28, 2023	SELL	$214.27 - $253.37 $9,213 - $10,894	-43 Reduced 3.64%	1,139 $252,000
Q1 2023 May 11, 2023	BUY	$225.79 - $275.2 $1,580 - $1,926	7 Added 0.6%	1,182 $285,000
Q4 2022 Jan 30, 2023	SELL	$229.03 - $291.01 $183,682 - $233,390	-802 Reduced 40.57%	1,175 $308,000
Q3 2022 Nov 03, 2022	BUY	$224.46 - $253.15 $112,230 - $126,575	500 Added 33.85%	1,977 $446,000
Q2 2022 Aug 02, 2022	SELL	$230.71 - $256.74 $14,996 - $16,688	-65 Reduced 4.22%	1,477 $359,000
Q1 2022 Apr 20, 2022	SELL	$219.27 - $242.57 $23,461 - $25,954	-107 Reduced 6.49%	1,542 $373,000
Q4 2021 Jan 12, 2022	SELL	$198.88 - $227.6 $15,313 - $17,525	-77 Reduced 4.46%	1,649 $371,000
Q3 2021 Oct 12, 2021	BUY	$212.27 - $248.7 $36,085 - $42,279	170 Added 10.93%	1,726 $367,000
Q2 2021 Aug 13, 2021	SELL	$233.58 - $259.14 $1,635 - $1,813	-7 Reduced 0.45%	1,556 $379,000
Q1 2021 Apr 14, 2021	BUY	$221.91 - $258.6 $346,845 - $404,191	1,563 New	1,563 $389,000

Others Institutions Holding AMGN

# of Institutions

3,122

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Shilanski & Associates, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Shilanski & Associates, Inc. with notifications on news.

Account

Shilanski & Associates, Inc. Amgen Inc Transaction History